Debut Plus

₹238.7

▲ +0.19 +0.08%

18 Jul 2026

NSE Listed · Healthcare

Medicamen Biotech Limited (MEDICAMEQ)

Volume: 9,29852W Range:₹212.4₹447.65
NSE BSE www.medicamen.com
Key Ratios
Checked just now
Market Cap₹324 Cr
Current Price₹238.7
Previous Close₹238.51
High / Low (52w)₹447.65 / ₹212.4
Volume9,298
Avg Vol (1W)—
Avg Vol (1M)—
Stock P/E33.02
Book Value₹234.32
Dividend Yield42%
ROE4.01%
ROA2.89%
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹7.23
P/B1.02
Debt / Equity17.34
50 DMA₹252.61
200 DMA₹311.74
Day change+0.08%
Price Chart
₹238.7▼ 41.04% · 1Y
₹474₹2241.8L
2025-07-18
2026-07-16

20-day avg volume: 37K shares

Pros
  • Pays a dividend yield of 42.0%.
  • Company is almost debt-free.
  • Revenue grew 22% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹61 Cr₹47 Cr₹47 Cr₹43 Cr₹30 Cr—
EBITDA₹7 Cr₹5 Cr₹6 Cr₹5 Cr₹4 Cr—
Net Profit₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr—
EPS3.281.211.561.181.47—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹198 Cr₹163 Cr₹179 Cr₹141 Cr—
EBITDA₹23 Cr₹20 Cr₹25 Cr₹26 Cr—
Net Profit₹10 Cr₹7 Cr₹11 Cr₹15 Cr—
EPS7.225.168.6311.73—
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹372 Cr₹297 Cr₹295 Cr₹279 Cr—
Total Liabilities₹96 Cr₹84 Cr₹88 Cr₹85 Cr—
Equity₹276 Cr₹212 Cr₹205 Cr₹193 Cr—
Total Debt₹48 Cr₹34 Cr₹31 Cr₹26 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹-33 Cr₹-8 Cr₹-7 Cr₹-6 Cr—
Investing₹-3 Cr₹-1 Cr₹-6 Cr₹-6 Cr—
Financing₹64 Cr₹-1 Cr₹6 Cr₹29 Cr—
Free Cash Flow₹-38 Cr₹-10 Cr₹-13 Cr₹-13 Cr—
Shareholding
Promoter 62.97% Institutions 0% Public 37.03%
About Medicamen Biotech Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

www.medicamen.com ↗
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Magellanic Cloud LimitedMcon Rasayan India Ltd.Multi Commodity ExchangeMarvel Decor LimitedGlobal Health LimitedMedi Assist Health Ser LimitedMedico Remedies LimitedMedicamen Organics Ltd.Medistep Healthcare Ltd.Medplus Health Serv Ltd.Meesho LimitedMega Flex Plastics Ltd.All “M” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search